Abstract
The purpose of this study is to report a case of retinal capillary hemangioma treated with ruthenium-106 brachytherapy combined with intravitreal bevacizumab. A 58-year-old woman presented with blurred vision in her left eye for 15 days. Best-corrected visual acuity (BCVA) was counting fingers at 3 m in her left eye. Examination showed a peripheral endophytic retinal capillary hemangioma, with associated macular edema and diffuse hard exudates in a macular star pattern. B-scan ultrasonography revealed a solid, highly reflective retinal tumor measuring 7.1 × 7.5 mm in basal dimension and 3.5 mm in thickness. The hemangioma and macular edema were treated with ruthenium-106 brachytherapy (500 Gy) followed 1 month later with an intravitreal injection of 1.25 mg (0.05 ml) bevacizumab. After 10 months of follow-up, examination demonstrated involution of the hemangioma, resolution of the macular edema, less hard exudates, and improvement of BCVA to 20/25. Ruthenium-106 brachytherapy combined with intravitreal bevacizumab was associated with significant involution of the choroidal hemangioma with resolution of the macular edema and improvement in visual acuity.
References
Webster AR, Maher ER, Bird AC, Gregor ZJ, Moore AT (1999) A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology 106:623–629. doi:10.1016/S0161-6420(99)90127-6
Rodriguez-Coleman H, Spaide RF, Yannuzzi LA (2002) Treatment of angiomatous lesions of the retina with photodynamic therapy. Retina 22:228–232. doi:10.1097/00006982-200204000-00019
Los M, Aarsman CJ, Terpstra L et al (1997) Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease. Ann Oncol 8:1015–1022. doi:10.1023/A:1008213320642
Chan CC, Vortmeyer AO, Chew EY et al (1999) VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol 117:625–630
Spaide RF, Fisher YL (2006) Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26:275–278. doi:10.1097/00006982-200603000-00004
Kreusel KM, Bornfeld N, Lommatzsch A, Wessing A, Foerster MH (1998) Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology 105(8):1386–1392. doi:10.1016/S0161-6420(98)98017-4
Murthy R, Hanovaz SG, Naik M, Gopi S, Reddy VA (2005) Ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal haemangioma in Sturge–Weber syndrome. Indian J Ophthalmol 53:274–275
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Russo, V., Stella, A., Barone, A. et al. Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangioma. Int Ophthalmol 32, 71–75 (2012). https://doi.org/10.1007/s10792-011-9513-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-011-9513-1